From advanced drops to personalized care, see what’s making a difference in dry eye management this year.
1. A new era in dry eye therapy: the semifluorinated alkane-based cyclosporine A eye drop, VEVYE
Priyanka Agarwal, PhD discusses the challenges in managing dry eye disease (DED) and introduces a new treatment platform using semifluorinated alkanes (SFAs) to stabilize the tear film and enhance ocular drug delivery. Specifically, VEVYE, a cyclosporine A-based solution, combines the tear film benefits of SFAs with anti-inflammatory effects, offering a dual approach that improves both the symptoms and underlying causes of DED, with a faster onset of action than other treatments.
Read more here.
2. Hyaluronic Acid and Trehalose: New Combination for Treating Dry Eye Disease
In his dry eye clinic, Dr. Kambiz Silani uses a combination of in-office treatments and at-home therapies, including lubricating eye drops with hyaluronic acid (HA) and trehalose, to effectively manage DED. Studies show that the combination of HA and trehalose improves tear film stability, reduces symptoms, and provides longer-lasting relief, making it particularly beneficial for patients with mild to severe DED, including those with contact lens intolerance.
Read more here.
3. Artificial Tears for Dry Eye Disease: Choose the Right Drops for Patients’ Individual Needs
Dr. Nathan Lighthizer emphasizes the importance of personalized artificial tear recommendations in managing DED, based on factors like disease severity, symptoms, and diagnostic results. He highlights the success of using preservative-free, high-quality artificial tears, such as iVizia, alongside in-office treatments like IPL and thermal expression, to improve patient outcomes and provide long-term relief for severe DED cases.
Read more here.
4. Top 3 factors linked to face mask-associated dry eye in medical students
A recent study found that medical students, especially those wearing N95 or loose-fit masks for 6 to 8 hours, are at higher risk for developing dry eye. The study highlights the importance of educating students on “face mask-appropriate behavior” to reduce the incidence of mask-associated dry eye, with 39.51% of students reporting symptoms, ranging from mild to severe.
Read more here.
5. Water-free VEVYE eye drops improve dry eye symptoms and adherence
Dr. Lauren Zimski highlights the effectiveness of VEVYE® (cyclosporine ophthalmic solution, 0.1%) for treating DED, noting its quick onset, superior tolerability, and significant symptom relief compared to other cyclosporine formulations. With clinical evidence supporting its benefits and patient testimonials reflecting improved adherence and comfort, VEVYE offers a promising treatment for those suffering from chronic, severe DED, especially in areas with harsh climates.
Read more here.
Related Content
